Advertisement

Medicare Copays For New Alzheimer's Drug Could Reach $11,500 Annually

Federal regulators approved the drug Aduhelm for Alzheimer's patients. (Biogen via AP)
Federal regulators approved the drug Aduhelm for Alzheimer's patients. (Biogen via AP)

Related:

Advertisement

More from WBUR

Listen Live
Close